NCT02433587

Short vs Long Duration Dual Antiplatelet Therapy in Patients Undergoing Lower Extremity Endovascular Revascularization

Evaluation of Short Versus Long Duration Dual Antiplatelet Therapy in Patients Undergoing Lower Extremity Endovascular Revascularization

• Status: Withdrawn
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: University Hospitals Cleveland Medical Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The primary objective of the trial is to evaluate short versus long duration dual antiplatelet therapy in patients undergoing lower extremity endovascular revascularization.

Conditions

• Peripheral Arterial Disease
• Endovascular Procedures

Interventions

Type	Name	Description
DRUG	Aspirin	Patients will take Aspirin 81 mg
DRUG	Clopidogrel	Patients will take Clopidogrel 75 mg

Timeline

• Start date: 2019-10-01
• Primary completion: 2021-07-01
• Completion: 2023-07-01
• First posted: 2015-05-05
• Last updated: 2019-10-07

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study